The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Orexin loss in Huntington's disease
Abstract
Huntington's disease (HD) is a devastating neurodegenerative disorder caused by an expanded CAG repeat in the gene encoding huntingtin, a protein of unknown function. Mutant huntingtin forms intracellular aggregates and is associated with neuronal death in select brain regions. The most studied mouse model (R6/2) of HD replicates many features of the disease, but has been reported to exhibit only very little neuronal death. We describe for the first time a dramatic atrophy and loss of orexin neurons in the lateral hypothalamus of R6/2 mice. Importantly, we also found a significant atrophy and loss of orexin neurons in Huntington patients. Like animal models and patients with impaired orexin function, the R6/2 mice were narcoleptic. Both the number of orexin neurons in the lateral hypothalamus and the levels of orexin in the cerebrospinal fluid were reduced by 72% in end-stage R6/2 mice compared with wild-type littermates, suggesting that orexin could be used as a biomarker reflecting neurodegeneration. Our results show that the loss of orexin is a novel and potentially very important pathology in HD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Sakurai, T., Amemiya, A., Ishii, M., Matsuzaki, I., Chemelli, R. M., Tanaka, H., Williams, S. C., Richardson, J. A., Kozlowski, G. P., Wilson, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)80949-6 · Cited by 5,501
The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity
de Lecea, L., Kilduff, T. S., Peyron, C., Gao, X.-B., Foye, P. E., Danielson, P. E., Fukuhara, C., Battenberg, E. L. F., Gautvik, V. T., Bartlett, F. S., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.322 · Cited by 3,878
Narcolepsy in orexin Knockout Mice
Chemelli, R. M., Willie, J. T., Sinton, C. M., Elmquist, J. K., Scammell, T., Lee, C., Richardson, J. A., Williams, S. C., Xiong, Y., Kisanuki, Y., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)81973-x · Cited by 3,095 · cited 4×
“Importantly, studies in mice with a null mutation of the gene for orexin (19) or one of its receptors (20) as well as transgenic mice with a targeted ablation of orexin neurons (21) revealed severe disturbances of sleep and wakefulness, similar to narcoleptic symptoms in humans (22).”
BackgroundMethodInfluentialMangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81369-0 · Cited by 3,073
Lin, L., Faraco, J., Li, R., Kadotani, H., Rogers, W., Lin, X., Qiu, X., de Jong, P. J., Nishino, S., & Mignot, E. (1999) · Cell · doi:10.1016/s0092-8674(00)81965-0 · Cited by 2,613
Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in Brain
DiFiglia, M., Sapp, E., Chase, K. O., Davies, S. W., Bates, G. P., Vonsattel, J. P., & Aronin, N. (1997) · Science · doi:10.1126/science.277.5334.1990 · Cited by 2,439
Neuropathological Classification of Huntingtonʼs Disease
VONSATTEL, J.-P., MYERS, R. H., STEVENS, T. J., FERRANTE, R. J., BIRD, E. D., & RICHARDSON, E. P. (1985) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-198511000-00003 · Cited by 2,227
Peyron, C., Faraco, J., Rogers, W., Ripley, B., Overeem, S., Charnay, Y., Nevsimalova, S., Aldrich, M., Reynolds, D., Albin, R., et al. (2000) · Nature Medicine · doi:10.1038/79690 · Cited by 2,118
Genetic Ablation of Orexin Neurons in Mice Results in Narcolepsy, Hypophagia, and Obesity
Hara, J., Beuckmann, C. T., Nambu, T., Willie, J. T., Chemelli, R. M., Sinton, C. M., Sugiyama, F., Yagami, K.-I., Goto, K., Yanagisawa, M., et al. (2001) · Neuron · doi:10.1016/s0896-6273(01)00293-8 · Cited by 1,403
Mignot, E., Lammers, G. J., Ripley, B., Okun, M., Nevsimalova, S., Overeem, S., Vankova, J., Black, J., Harsh, J., Bassetti, C., et al. (2002) · Archives of Neurology · doi:10.1001/archneur.59.10.1553 · Cited by 1,126
Distinct Narcolepsy Syndromes in Orexin Receptor-2 and Orexin Null Mice
Willie, J. T., Chemelli, R. M., Sinton, C. M., Tokita, S., Williams, S. C., Kisanuki, Y. Y., Marcus, J. N., Lee, C., Elmquist, J. K., Kohlmeier, K. A., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00330-1 · Cited by 645
Energetics in the pathogenesis of neurodegenerative diseases
Beal, M. F. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01584-8 · Cited by 474
Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease
Turmaine, M., Raza, A., Mahal, A., Mangiarini, L., Bates, G. P., & Davies, S. W. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.110078997 · Cited by 430
CSF hypocretin/orexin levels in narcolepsy and other neurological conditions
Ripley, B., Overeem, S., Fujiki, N., Nevsimalova, S., Uchino, M., Yesavage, J., Di Monte, D., Dohi, K., Melberg, A., Lammers, G. J., et al. (2001) · Neurology · doi:10.1212/wnl.57.12.2253 · Cited by 415
Loss of normal huntingtin function: new developments in Huntington's disease research
Cattaneo, E. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01721-5 · Cited by 382
Sleep and quantitative EEG in neurodegenerative disorders
Petit, D., Gagnon, J.-F., Fantini, M. L., Ferini-Strambi, L., & Montplaisir, J. (2004) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2004.02.001 · Cited by 348
Cepeda, C., Hurst, R. S., Calvert, C. R., Hernández-Echeagaray, E., Nguyen, O. K., Jocoy, E., Christian, L. J., Ariano, M. A., & Levine, M. S. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-03-00961.2003 · Cited by 321
Behrens, P. F. (2002) · Brain · doi:10.1093/brain/awf180 · Cited by 320
Mouse models of Huntington's disease
Menalled, L. B., & Chesselet, M.-F. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01884-8 · Cited by 315
Impaired Glutamate Uptake in the R6 Huntington's Disease Transgenic Mice
Liévens, J.-C., Woodman, B., Mahal, A., Spasic-Boscovic, O., Samuel, D., Kerkerian-Le Goff, L., & Bates, G. P. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0430 · Cited by 313
Hypocretin (OREXIN): Role in Normal Behavior and Neuropathology
Siegel, J. M. (2004) · Annual Review of Psychology · doi:10.1146/annurev.psych.55.090902.141545 · Cited by 246
Siegel, J. M. (1999) · Cell · doi:10.1016/s0092-8674(00)81969-8 · Cited by 234
Hansson, O., Petersén, Å., Leist, M., Nicotera, P., Castilho, R. F., & Brundin, P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8727 · Cited by 228
Self-citationExperimental therapeutics in transgenic mouse models of Huntington's disease
Beal, M. F., & Ferrante, R. J. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1386 · Cited by 222
Beuckmann, C. T., Sinton, C. M., Williams, S. C., Richardson, J. A., Hammer, R. E., Sakurai, T., & Yanagisawa, M. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.5560-03.2004 · Cited by 183
Atrophy of the Hypothalamic Lateral Tuberal Nucleus in Huntingtonʼs Disease
Kremer, H. P. H., Roos, R. A. C., Dingjan, G., Bots, G. T. A. M., & Maran, E. (1990) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199007000-00002 · Cited by 172
Self-citationWild-Type Huntingtin Plays a Role in Brain Development and Neuronal Survival
Reiner, A., Dragatsis, I., Zeitlin, S., & Goldowitz, D. (2003) · Molecular Neurobiology · doi:10.1385/mn:28:3:259 · Cited by 165
Hansson, O., Guatteo, E., Mercuri, N. B., Bernardi, G., Li, X., Castilho, R. F., & Brundin, P. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01767.x · Cited by 165
Self-citationAbnormal association of mutant huntingtin with synaptic vesicles inhibits glutamate release
Li, H., Wyman, T., Yu, Z.-X., Li, S.-H., & Li, X.-J. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg218 · Cited by 157
Morton, A. J., Lagan, M., Skepper, J. N., & Dunnett, S. B. (2000) · Journal of Neurocytology · doi:10.1023/a:1010887421592 · Cited by 138
Li, S.-H., Yu, Z.-X., Li, C.-L., Nguyen, H. P., Zhou, Y., Deng, C., & Li, X. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-17-06956.2003 · Cited by 136
Huntingtin inclusions do not deplete polyglutamine-containing transcription factors in HD mice
Yu, Z.-X., Li, S.-H., Nguyen, H.-P., & Li, X.-J. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.8.905 · Cited by 130
Kremer, H. P. H., Roos, R. A. C., Dingjan, G. M., Bots, G. T. A. M., Bruyn, G. W., & Hofman, M. A. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90443-w · Cited by 121
Self-citationProgressive retinal degeneration and dysfunction in R6 Huntington's disease mice
Helmlinger, D., Yvert, G., Picaud, S., Merienne, K., Sahel, J., Mandel, J.-L., & Devys, D. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.26.3351 · Cited by 105
Distribution of Inclusions in Neuronal Nuclei and Dystrophic Neurites in Huntington Disease Brain
Maat–Schieman, M. L. C., Dorsman, J. C., Smoor, M. A., Siesling, S., van Duinen, S. G., Verschuuren, J. J. G. M., den Dunnen, J. T., van Ommen, G. B., & Roos, R. A. C. (1999) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199902000-00003 · Cited by 97
Self-citationNicNiocaill, B., Haraldsson, B., Hansson, O., O'Connor, W. T., & Brundin, P. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2000.01379.x · Cited by 94
Self-citationEarly Alterations in Gene Expression and Cell Morphology in a Mouse Model of Huntington's Disease
Iannicola, C., Moreno, S., Oliverio, S., Nardacci, R., Ciofi-Luzzatto, A., & Piacentini, M. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750830.x · Cited by 74
Mikkelsen, J. D., Hauser, F., de Lecea, L., Sutcliffe, J. G., Kilduff, T. S., Calgari, C., Pévet, P., & Simonneaux, V. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01655.x · Cited by 66
Excitotoxic degeneration of hypothalamic orexin neurons in slice culture
Katsuki, H., & Akaike, A. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.09.003 · Cited by 37
Huntington's disease: The mystery unfolds?
Petersén, Å., & Brundin, P. (2002) · International review of neurobiology · doi:10.1016/s0074-7742(02)53012-9 · Cited by 13
Self-citation
Cited by
Molecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease
Zuccato, C., Valenza, M., & Cattaneo, E. (2010) · Physiological Reviews · doi:10.1152/physrev.00041.2009 · Cited by 848
Gray, M., Shirasaki, D. I., Cepeda, C., Andre, V. M., Wilburn, B., Lu, X.-H., Tao, J., Yamazaki, I., Li, S.-H., Sun, Y. E., et al. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0857-08.2008 · Cited by 613
Mechanisms of neurodegeneration in Huntington’s disease
Gil, J. M., & Rego, A. C. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06310.x · Cited by 471
Self-citationMicroglial activation correlates with severity in Huntington disease: A clinical and PET study
Pavese, N., Gerhard, A., Tai, Y. F., Ho, A. K., Turkheimer, F., Barker, R. A., Brooks, D. J., & Piccini, P. (2006) · Neurology · doi:10.1212/01.wnl.0000222734.56412.17 · Cited by 462
Disintegration of the sleep-wake cycle and circadian timing in Huntington's disease
Morton, A. J., Wood, N. I., Hastings, M. H., Hurelbrink, C., Barker, R. A., & Maywood, E. S. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3842-04.2005 · Cited by 403
Metadata
- Authors
- Petersén, Å., Gil, J., Maat-Schieman, M. L. C., Björkqvist, M., Tanila, H., Araújo, I. M., Smith, R., Popovic, N., Wierup, N., Norlén, P., Li, J.-Y., Roos, R. A. C., Sundler, F., Mulder, H., & Brundin, P.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-11-03
- Volume
- 14
- Issue
- 1
- Pages
- 39-47
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2133014036
- Cited by
- 271
- References
- 41
- FWCI
- 4.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.